Strides Arcolab shares sink on dividend worries
MUMBAI (Reuters) - Shares in drugmaker Strides Arcolab (STAR.NS) plummeted about 10 percent on Thursday, wiping out early gains following its sale of a unit to Mylan (MYL.O) for $1.6 billion, as investors were unhappy with Strides' dividend payout, traders said.
The shares had initially gained as much as 13.2 percent.
The company declared a 20 percent dividend, or 2 rupees per share, for 2012.
Strides' injectables unit Agila Specialties generated $700 million in sales and an operating profit of $86 million in year 2012, Strides said.
The Bangalore-based drugmaker said it planned to spend $700 million to $800 million at pretax level on shareholders.
Valued at $1.1 billion, shares in Strides Arcolab were down 8.5 percent at 902.95 rupees by 9:51 a.m. when the Mumbai market was up 0.55 percent.
(Reporting by Kaustubh Kulkarni; Editing by Gopakumar Warrier)
- Tweet this
- Share this
- Digg this
- UPDATE 3-Boeing, SpaceX win contracts to build 'space taxis' for NASA
- Apple iPhone 6 pre-orders hit record 4 million on first day
- Pakistani Islamists use floods to turn opinion against India
- Iraqi official briefs Syria's Assad on efforts against Islamic State
- Google launches $105 Android One; eyes low-price smartphone boom
The electricity board in this Indian city has been instructed to avoid any power cuts and officials have been told to have their shoes polished and their shirts tucked in: Nothing has been left to chance for this week's visit by Chinese President Xi Jinping. Full Article
Climate smart farmers get tech savvy to save India's bread basket. Full Article